by Sarah Boseley
The Guardian, 8 June 2017
Drugs that have been hailed as a cure for a debilitating and sometimes fatal liver disease – but have threatened to break the health budgets of most countries because of their cost – have not been proven to have any effect, according to a new review. The startling conclusion came from the respected and independent Cochrane Collaboration, which has assessed all the drug company trials of the breakthrough hepatitis C treatments. The Cochrane Collaboration has published a review of all the randomised controlled trials conducted by the manufacturers in order to get the drugs licensed. It finds that the drugs may clear the virus from the blood, but there is no evidence that they prevent harm from disease or save lives.